Table 4.
Analysis of correlations between the plasma levels of SCL and IL-6 within the study group and the control group and the age of the subjects (R–correlation coefficient).
| Parameter | Sclerostin | Interleukin 6 | |||
|---|---|---|---|---|---|
| Study Group (n = 34) | Control Group (n = 31) | Study Group (n = 34) | Control Group (n = 32) | ||
| E0 | R | 0.14 | 0.34 | 0.08 | 0.46 |
| p-value | 0.4018 | 0.0588 | 0.6570 | 0.0101 * | |
| E3 | R | 0.53 | 0.48 | 0.02 | 0.52 |
| p-value | 0.014 * | 0.0058 * | 0.9281 | 0.0026 * | |
| E6 | R | 0.27 | 0.30 | 0.16 | 0.41 |
| p-value | 0.1272 | 0.0915 | 0.3412 | 0.0205 * | |
E0—measurement at study entry; E3—measurement after 3 months of the study; E6—measurement after 6 months of the study; R—correlation coefficient; p-value—statistical significance; *—statistically significant parameter; n—number.